Inviting an author to review:
Find an author and click ‘Invite to review selected article’ near their name.
Search for authorsSearch for similar articles
19
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Better recognition, diagnosis and management of non-IgE-mediated cow’s milk allergy in infancy: iMAP—an international interpretation of the MAP (Milk Allergy in Primary Care) guideline

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Cow’s milk allergy (CMA) is one of the most common presentations of food allergy seen in early childhood. It is also one of the most complex food allergies, being implicated in IgE-mediated food allergy as well as diverse manifestations of non-IgE-mediated food allergy. For example, gastrointestinal CMA may present as food protein induced enteropathy, enterocolitis or proctocolitis. Concerns regarding the early and timely diagnosis of CMA have been highlighted over the years. In response to these, guideline papers from the United Kingdom (UK), Australia, Europe, the Americas and the World Allergy Organisation have been published. The UK guideline, ‘Diagnosis and management of non-IgE-mediated cow’s milk allergy in infancy—a UK primary care practical guide’ was published in this journal in 2013. This Milk Allergy in Primary Care (MAP) guideline outlines in simple algorithmic form, both the varying presentations of cow’s milk allergy and also focuses on the practical management of the most common presentation, namely mild-to-moderate non-IgE-mediated allergy. Based on the international uptake of the MAP guideline, it became clear that there was a need for practical guidance beyond the UK. Consequently, this paper presents an international interpretation of the MAP guideline to help practitioners in primary care settings around the world. It incorporates further published UK guidance, feedback from UK healthcare professionals and affected families and, importantly, also international guidance and expertise.

          Electronic supplementary material

          The online version of this article (doi:10.1186/s13601-017-0162-y) contains supplementary material, which is available to authorized users.

          Related collections

          Most cited references22

          • Record: found
          • Abstract: found
          • Article: not found

          BSACI guideline for the diagnosis and management of cow's milk allergy.

          This guideline advises on the management of patients with cow's milk allergy. Cow's milk allergy presents in the first year of life with estimated population prevalence between 2% and 3%. The clinical manifestations of cow's milk allergy are very variable in type and severity making it the most difficult food allergy to diagnose. A careful age- and disease-specific history with relevant allergy tests including detection of milk-specific IgE (by skin prick test or serum assay), diagnostic elimination diet, and oral challenge will aid in diagnosis in most cases. Treatment is advice on cow's milk avoidance and suitable substitute milks. Cow's milk allergy often resolves. Reintroduction can be achieved by the graded exposure, either at home or supervised in hospital depending on severity, using a milk ladder. Where cow's milk allergy persists, novel treatment options may include oral tolerance induction, although most authors do not currently recommend it for routine clinical practice. Cow's milk allergy must be distinguished from primary lactose intolerance. This guideline was prepared by the Standards of Care Committee (SOCC) of the British Society for Allergy and Clinical Immunology (BSACI) and is intended for clinicians in secondary and tertiary care. The recommendations are evidence based, but where evidence is lacking the panel of experts in the committee reached consensus. Grades of recommendation are shown throughout. The document encompasses epidemiology, natural history, clinical presentations, diagnosis, and treatment. © 2014 John Wiley & Sons Ltd.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Can we identify patients at risk of life-threatening allergic reactions to food?

            Anaphylaxis has been defined as a 'severe, life-threatening generalized or systemic hypersensitivity reaction'. However, data indicate that the vast majority of food-triggered anaphylactic reactions are not life-threatening. Nonetheless, severe life-threatening reactions do occur and are unpredictable. We discuss the concepts surrounding perceptions of severe, life-threatening allergic reactions to food by different stakeholders, with particular reference to the inclusion of clinical severity as a factor in allergy and allergen risk management. We review the evidence regarding factors that might be used to identify those at most risk of severe allergic reactions to food, and the consequences of misinformation in this regard. For example, a significant proportion of food-allergic children also have asthma, yet almost none will experience a fatal food-allergic reaction; asthma is not, in itself, a strong predictor for fatal anaphylaxis. The relationship between dose of allergen exposure and symptom severity is unclear. While dose appears to be a risk factor in at least a subgroup of patients, studies report that individuals with prior anaphylaxis do not have a lower eliciting dose than those reporting previous mild reactions. It is therefore important to consider severity and sensitivity as separate factors, as a highly sensitive individual will not necessarily experience severe symptoms during an allergic reaction. We identify the knowledge gaps that need to be addressed to improve our ability to better identify those most at risk of severe food-induced allergic reactions.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Prevalence and cumulative incidence of food hypersensitivity in the first 3 years of life.

              Prevalence and incidence of food hypersensitivity (FHS) and its trends in early childhood are unclear. A birth cohort born on the Isle of Wight (UK) between 2001 and 2002 was followed-up prospectively. Children were clinically examined and skin prick tested at set times and invited for food challenges when indicated. Nine hundred and sixty-nine children were recruited and 92.9%, 88.5% and 91.9% of them respectively were assessed at 1, 2 and 3 years of age. Prevalence of sensitization to foods was 2.2%, 3.8% and 4.5% respectively at these ages. Cumulatively, 5.3% [95% confidence interval (CI): 3.9-7.1] children were sensitized to a food. Using open food challenge and a good clinical history, the cumulative incidence of FHS was 6.0% (58/969, 95% CI: 4.6-7.7). Based on double-blinded, placebo-controlled, food challenge (DBPCFC) and a good clinical history, the cumulative incidence was 5.0% (48/969, 95% CI: 3.7-6.5). There is no evidence to suggest that the incidence of FHS has increased, comparing these results with previous studies. Overall, 33.7% of parents reported a food-related problem and of these, 16.1% were diagnosed with FHS by open challenge and history and 12.9% by DBPCFC and history. Main foods implicated were milk, egg and peanut. By the age of 3 years, 5-6% of children suffer from FHS based on food challenges and a good clinical history. There were large discrepancies between reported and diagnosed FHS. Comparing our data with a study performed in the USA more than 20 years ago, there were no significant differences in the cumulative incidence of FHS.
                Bookmark

                Author and article information

                Contributors
                carina.venter@childrenscolorado.org
                trevorbrown65@hotmail.co.uk
                r.meyer@imperial.ac.uk
                Joanne.walsh@nhs.net
                Neil.Shah@gosh.nhs.uk
                anna.nowak-wegrzyn@mssm.edu
                tongxinc@sjtu.edu.cn
                David.Fleischer@childrenscolorado.org
                ralf.heine@rch.org.au
                michael.levin@uct.ac.za
                viera.mcv@gmail.com
                020 7188 6410 , adam.fox@gstt.nhs.uk
                Journal
                Clin Transl Allergy
                Clin Transl Allergy
                Clinical and Translational Allergy
                BioMed Central (London )
                2045-7022
                23 August 2017
                23 August 2017
                2017
                : 7
                : 26
                Affiliations
                [1 ]Section of Allergy and Immunology, University of Colorado Denver School of Medicine, Children’s Hospital Colorado , Box B518, 13123 East 16th Avenue, Anschutz Medical Campus, Aurora, CO 80045 USA
                [2 ]ISNI 0000 0004 0389 6754, GRID grid.416994.7, Children’s Allergy Service, , Ulster Hospital, ; Belfast, BT16 1RH Northern Ireland, UK
                [3 ]ISNI 0000 0001 2113 8111, GRID grid.7445.2, Department Paediatrics, , Imperial College, London, ; London, W2 1NY UK
                [4 ]Gurney Surgery, Castle Partnership, 101-103 Magdalen Street, Norwich, NR3 1LN UK
                [5 ]GRID grid.420468.c, Gastroenterology Department, , Great Ormond Street Hospital, ; London, WC1N 3JH UK
                [6 ]ISNI 0000 0001 0670 2351, GRID grid.59734.3c, Jaffe Food Allergy Institute, , Icahn School of Medicine at Mount Sinai, ; New York, NY 10029 USA
                [7 ]ISNI 0000 0004 0368 8293, GRID grid.16821.3c, Department of Allergy and Immunology, Shanghai Children’s Medical Center, , Shanghai Jiao Tong University School of Medicine, ; 1678 Dongfang Road, Shanghai, 200127 China
                [8 ]ISNI 0000 0000 9442 535X, GRID grid.1058.c, Royal Children’s Hospital Melbourne, , Murdoch Children’s Research Institute, ; Parkville, VIC 3052 Australia
                [9 ]ISNI 0000 0004 1937 1151, GRID grid.7836.a, Division of Paediatric Allergy and Asthma, Red Cross War Memorial Children’s Hospital, , University of Cape Town, ; Room 516, ICH Building, Cape Town, South Africa
                [10 ]ISNI 0000 0000 8601 0541, GRID grid.412522.2, Centro de Gastroenterologica Pediatrica, Department of Paediatrics, Hospital Pequeno Principe, , Pontificia Universidade Catolica do Parana, ; Curitiba, Brazil
                [11 ]ISNI 0000 0004 0581 2008, GRID grid.451052.7, Department of Paediatric Allergy, , Guys and St Thomas’ Hospitals NHS Foundation Trust, ; London, UK
                [12 ]ISNI 0000 0001 2322 6764, GRID grid.13097.3c, Division of Asthma, Allergy and Lung Biology, , King’s College, London, ; London, UK
                Article
                162
                10.1186/s13601-017-0162-y
                5567723
                28852472
                e4bb48dc-fef9-4a8f-8ae9-108f9ea9d1d5
                © The Author(s) 2017

                Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License ( http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

                History
                : 28 December 2016
                : 30 June 2017
                Categories
                Review
                Custom metadata
                © The Author(s) 2017

                Immunology
                Immunology

                Comments

                Comment on this article